Research Progress in the Pathogenesis of Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Alzheimer's disease (AD) is a kind of chronic degenerative disease of the central nervous system, characteristics of cognitive dysfunction, and behavioral disability. The pathological changes include the formation of senile plaques-containing beta-amyloid (Aβ), neurofibrillary tangles (NFTs), loss of neurons, and synapses. So far, the pathogenesis of AD is still unclear. This study was aimed to review the major pathogenesis of AD-related to the published AD studies in recent 20 years. DATA SOURCES: The author retrieved information from the PubMed database up to January 2018, using various search terms and their combinations, including AD, Aβ, NFTs, pathogenesis, and genetic mutation. STUDY SELECTION: The author included data from peer-reviewed journals printed in English and Chinese on pathophysiological factors in AD. He organized these informations to explain the possible pathogenesis in AD. RESULTS: There are many amounts of data supporting the view that AD pathogenesis so far there mainly are Aβ toxicity, tau protein, gene mutation, synaptic damages, intermediate neurons and network abnormalities, changes in mitochondrial function, chemokines, etc., Its nosogenesis may be involved in multiple theories and involved in multiple molecular signaling pathways, including Aβ, tau protein, and synaptic anomaly; mutual relationship between the mechanisms urge jointly neuronal degeneration. CONCLUSIONS: This review highlights the research advances in the pathogenesis of AD. Future research has needed to fully disclose the association between multiple pathogenesis at the same time to interdict multiple signaling pathways, etc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Even so, accumulational soluble Aβ oligomer can damage synaptic junction and generate neurovirulence.[9] In pathology situation, the unbalance between the production and clearance rate of Aβ can lead to its sedimentation, causing for AD to happen using tau protein poisonousness, destroying intracellular calcium homeos…”
BackgroundComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 2×
“Meanwhile, it was ago taken for that synaptic loss was the secondary change of protein denaturation, but the research of Hong et al.[21] found that at the beginning of the AD cynapses could be already reduced and the decrease maybe is anterior to the formation of plaques, but from the abnormal of synaptic pruning mech…”
ResultForette, F., Seux, M.-L., Staessen, J. A., Thijs, L., Birkenhäger, W. H., Babarskiene, M.-R., Babeanu, S., Bossini, A., Gil-Extremera, B., Girerd, X., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03086-4 · Cited by 1,441
Gamma frequency entrainment attenuates amyloid load and modifies microglia
Iaccarino, H. F., Singer, A. C., Martorell, A. J., Rudenko, A., Gao, F., Gillingham, T. Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. (2016) · Nature · doi:10.1038/nature20587 · Cited by 1,328 · cited 1×
“Recent studies show that Aβ sedimentation can be reduced illuminating mice by 40 Hz LED lamp.[10] However contrary to what is always believed that Aβ oligomers have cytotoxicity, there is research[11] finding that Aβ oligomerization can have also protective effect and confront the infection of microorganisms and worms…”
BackgroundKumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · cited 1×
“[10] However contrary to what is always believed that Aβ oligomers have cytotoxicity, there is research[11] finding that Aβ oligomerization can have also protective effect and confront the infection of microorganisms and worms in the body.”
BackgroundMacroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967 · cited 1×
“[61] Gene expression technique suggested that in AD patient brain tissue, Beclinl mRNA expression was decreased, Beclinl hypoproteinia and mature autophagy formation obstacle, leading to autophagic vesicles concentrated, and Aβ increased formation.[62] Autophagic inhibitor might more activate γ‐secretase more than ind…”
BackgroundChesler, E. J., Lu, L., Shou, S., Qu, Y., Gu, J., Wang, J., Hsu, H. C., Mountz, J. D., Baldwin, N. E., Langston, M. A., et al. (2005) · Nature Genetics · doi:10.1038/ng1518 · Cited by 719
Zempel, H., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2357-10.2010 · Cited by 686
The Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., & Scheper, W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080814 · Cited by 600
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S.-I., Dziewczapolski, G., Nakamura, T., Cao, G., Pratt, A. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306832110 · Cited by 600
Imaging synaptic density in the living human brain
Finnema, S. J., Nabulsi, N. B., Eid, T., Detyniecki, K., Lin, S.-F., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6667 · Cited by 575
Dendritic Inhibition in the Hippocampus Supports Fear Learning
Lovett-Barron, M., Kaifosh, P., Kheirbek, M. A., Danielson, N., Zaremba, J. D., Reardon, T. R., Turi, G. F., Hen, R., Zemelman, B. V., & Losonczy, A. (2014) · Science · doi:10.1126/science.1247485 · Cited by 509
Gauthier, S., Feldman, H. H., Schneider, L. S., Wilcock, G. K., Frisoni, G. B., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Wischik, D. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31275-2 · Cited by 427 · cited 6×
“[18] Research[19] challenges the neurotoxic effects of tau phosphorylation in AD nosogenesis and the research found that at least in the early stage of AD, phosphorylation of characteristic sites in tau protein was able to inhibit the toxicity of Aβ, being that tau phosphorylation‑mediated by p38MAPK can antagonize th…”
BackgroundInfluentialCordy, J. M., Hussain, I., Dingwall, C., Hooper, N. M., & Turner, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635130100 · Cited by 356
González, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352 · cited 1×
“[53] MG’s role of inflammation in AD is similar to the previous statement.[54] MG in the circumference of Aβ plaques is M1 phenotype and was activated as inflammatory or nerve toxicity phenotype under the action of miR‐689, miR‐124 and miR‐155,[55] meanwhile to inhibit MG to the M2 phenotype.”
ResultCACNA1C (Cav1.2) in the pathophysiology of psychiatric disease
Bhat, S., Dao, D. T., Terrillion, C. E., Arad, M., Smith, R. J., Soldatov, N. M., & Gould, T. D. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.001 · Cited by 271
Söllvander, S., Nikitidou, E., Brolin, R., Söderberg, L., Sehlin, D., Lannfelt, L., & Erlandsson, A. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0098-z · Cited by 267
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice
Ittner, A., Chua, S. W., Bertz, J., Volkerling, A., van der Hoven, J., Gladbach, A., Przybyla, M., Bi, M., van Hummel, A., Stevens, C. H., et al. (2016) · Science · doi:10.1126/science.aah6205 · Cited by 263
Jazvinšćak Jembrek, M., Hof, P. R., & Šimić, G. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/346783 · Cited by 244
Sanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0896-x · Cited by 222 · cited 1×
“homeostasis imbalance, caused endoplasmic reticulum stress (ERS),[68] playing an important role in the pathogenesis of AD and the apoptosis of nerve cells.”
BackgroundReplication of CLU, CR1, and PICALM Associations With Alzheimer Disease
Carrasquillo, M. M., Belbin, O., Hunter, T. A., Ma, L., Bisceglio, G. D., Zou, F., Crook, J. E., Pankratz, V. S., Dickson, D. W., Graff-Radford, N. R., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.147 · Cited by 208 · cited 1×
“[1] For SAD >90% of AD, major influencing genes include apolipoprotein E (ApoE) gene, clusterin gene, complement receptor 1 gene, and phospholipids bind to clathrin protein (PICALM) gene.[2] Along with the development of genetic research into AD, more new genetic loci for AD have been discovered, including cholesterol…”
BackgroundBlanch, M., Mosquera, J. L., Ansoleaga, B., Ferrer, I., & Barrachina, M. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.10.004 · Cited by 192 · cited 1×
“[28] The classic CpG site and noncpg site 5mC levels in the mtDNA D‐loop area of the cerebral cortex mtDNA markedly increased, the extent of increase proportional to the stages and severity of the disease, and the 5mC level of mitochondrial NADH dehydrogenase subunit1 gene increased slightly, along with upregulation o…”
BackgroundKulijewicz‐Nawrot, M., Verkhratsky, A., Chvátal, A., Syková, E., & Rodríguez, J. J. (2012) · Journal of Anatomy · doi:10.1111/j.1469-7580.2012.01536.x · Cited by 160 · cited 1×
“[60] Extracellular accumulated Aβ induces the activation of AS, activated AS in the brain of AD mouse mainly distributed in the hippocampal area, the inner smell and the prefrontal cortex,[56] this discovery consistent with the inner olfactory cortex and the prefrontal cortex mostly easily injured by AD.”
BackgroundKamphuis, W., Kooijman, L., Orre, M., Stassen, O., Pekny, M., & Hol, E. M. (2015) · Glia · doi:10.1002/glia.22800 · Cited by 155
Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure
Amin, N. D., Bai, G., Klug, J. R., Bonanomi, D., Pankratz, M. T., Gifford, W. D., Hinckley, C. A., Sternfeld, M. J., Driscoll, S. P., Dominguez, B., et al. (2015) · Science · doi:10.1126/science.aad2509 · Cited by 154 · cited 1×
“miRNA is endogenous noncoding small molecule RNA and can involve in regulating the development and function of nervous system.[33] miR‐137 (or miRNA‐137) as a member of miRNA takes part in pathogenetic process of a variety of neurological diseases including AD.”
BackgroundA critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
Reddy, P. H., Tonk, S., Kumar, S., Vijayan, M., Kandimalla, R., Kuruva, C. S., & Reddy, A. P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.067 · Cited by 143
Examination of the current top candidate genes for AD in a genome-wide association study
Feulner, T. M., Laws, S. M., Friedrich, P., Wagenpfeil, S., Wurst, S. H. R., Riehle, C., Kuhn, K. A., Krawczak, M., Schreiber, S., Nikolaus, S., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.141 · Cited by 128 · cited 1×
“Chinese Medical Journal ¦ July 5, 2018 ¦ Volume 131 ¦ Issue 13 1619 and CH24H),[3] Sterol O‐acyltransferase (Soat1) and prostaglandin‐endoperoxide synthase 2 (Ptgs2)[4] genes, and angiotensin‐converting enzyme gene[5] are some of these.”
BackgroundMicroglia: unique and common features with other tissue macrophages
Prinz, M., Tay, T. L., Wolf, Y., & Jung, S. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1267-1 · Cited by 126 · cited 1×
“MGs are highly specialized histological macrophages in CNS, similar to the peripheral mononuclear phagocytic system in function and origin.[52] Megalophages differentiate into two types of antagonistic phenotypes in the immune response: the M1 phenotype that causes tissue damage and the M2 phenotype that promotes tiss…”
BackgroundLee, S.-H., Le Pichon, C. E., Adolfsson, O., Gafner, V., Pihlgren, M., Lin, H., Solanoy, H., Brendza, R., Ngu, H., Foreman, O., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.099 · Cited by 125 · cited 1×
“accelerate the clearing to tau protein, and protect nerve cell from the toxic effect induced by tau.[18] Research[19]”
BackgroundCytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice
Babcock, A. A., Ilkjær, L., Clausen, B. H., Villadsen, B., Dissing-Olesen, L., Bendixen, A. T. M., Lyck, L., Lambertsen, K. L., & Finsen, B. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.006 · Cited by 107 · cited 1×
“[54] MG in the circumference of Aβ plaques is M1 phenotype and was activated as inflammatory or nerve toxicity phenotype under the action of miR‐689, miR‐124 and miR‐155,[55] meanwhile to inhibit MG to the M2 phenotype.”
Background
Cited by
Advance of sporadic Alzheimer's disease animal models
Zhang, L., Chen, C., Mak, M. S., Lu, J., Wu, Z., Chen, Q., Han, Y., Li, Y., & Pi, R. (2020) · Medicinal Research Reviews · doi:10.1002/med.21624 · Cited by 116
Zheng, Y., Zhang, X., Zhang, R., Wang, Z., Gan, J., Gao, Q., Yang, L., Xu, P., & Jiang, X. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5314 · Cited by 52
“The pathogenesis of Ad is multifactorial and involves a number of hypotheses, including the cholinergic theory, the amyloid cascade theory, the oxidative stress theory, the tau protein hypothesis and the neuroinflammation hypothesis (4).”
BackgroundDiverse roles of ceramide in the progression and pathogenesis of Alzheimer's disease
Chowdhury, M. R., Jin, H. K., & Bae, J.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10081956 · Cited by 47
MicroRNA-140 silencing represses the incidence of Alzheimer’s disease
Liang, C., Mu, Y., Tian, H., Wang, D., Zhang, S., Wang, H., Liu, Y., & Di, C. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135674 · Cited by 39
Metadata
- Authors
- Chen, Y.-G.
- Venue
- Chinese Medical Journal
- Published
- 2018-07-05
- Volume
- 131
- Issue
- 13
- Pages
- 1618-1624
- ISSN
- 0366-6999 (ISSN-L)
- OpenAlex
- W2809744404
- Cited by
- 136
- References
- 30
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.